Eden Research
EDEN · AIM · Chemicals · mcap £19m · 2.3p
Financials · LTM to 31 Mar 26
Source: results 26 Aug 26 ↗
- Revenue
- £4.3m
- Operating profit
- −£2.2m
- Net income
- −£1.9m
- Free cash flow
- −£3.8m
- Net cash
- £1.5m
- Market cap
- £18.9m
- EV / EBIT
- –
- FCF yield
- −19.9%
- Price / book
- 1.5×
Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.
Latest report: FY 24 (twelve months to 31 Dec 24), published 26 Aug 26 · read the results ↗
£m unless stated · newest first · italic = calculated (LTM, H2 = FY − H1) · hover a value for its source
| FY 24 | |
|---|---|
| Revenue | 4.3 |
| Gross profit | 1.9 |
| Operating profit | (2.2) |
| Amortisation | (0.4) |
| Share-based payments | (0.2) |
| Finance costs | (0.0) |
| Profit before tax | (2.2) |
| Tax | 0.3 |
| Net income (owners) | (1.9) |
| EPS basic | (0.4p) |
| EPS diluted | (0.4p) |
| FY 24 | |
|---|---|
| Cash from operations | (1.0) |
| Capex (PP&E) | (0.0) |
| Capex (intangibles) | (2.5) |
| Lease principal paid | (0.1) |
| Lease interest paid | (0.0) |
| Latest Mar 26 | FY 24 | |
|---|---|---|
| Other intangibles | 8.7 | 6.9 |
| Property, plant & equipment | 0.1 | 0.2 |
| Associates & JVs | 0.2 | 0.3 |
| Inventories | 0.6 | 0.5 |
| Trade receivables | 4.1 | 3.1 |
| Cash | 1.5 | 3.7 |
| Trade payables | 3.2 | 3.4 |
| Lease liabilities, current | 0.2 | 0.1 |
| Lease liabilities, non-current | 0.5 | 0.1 |
| Non-controlling interests | 0.0 | 0.0 |
| Total equity | 12.4 | 11.8 |
Line items extracted automatically from each results announcement; when a later report restates a period, the later figure is shown. LTM and H2 are calculated from reported periods. Check the source before relying on a figure.
Company filings. Not investment advice.